1. Home
  2. GKOS vs BOOT Comparison

GKOS vs BOOT Comparison

Compare GKOS & BOOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • BOOT
  • Stock Information
  • Founded
  • GKOS 1998
  • BOOT 1978
  • Country
  • GKOS United States
  • BOOT United States
  • Employees
  • GKOS N/A
  • BOOT N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • BOOT Clothing/Shoe/Accessory Stores
  • Sector
  • GKOS Health Care
  • BOOT Consumer Discretionary
  • Exchange
  • GKOS Nasdaq
  • BOOT Nasdaq
  • Market Cap
  • GKOS 5.4B
  • BOOT 5.7B
  • IPO Year
  • GKOS 2015
  • BOOT 2014
  • Fundamental
  • Price
  • GKOS $91.09
  • BOOT $184.05
  • Analyst Decision
  • GKOS Strong Buy
  • BOOT Strong Buy
  • Analyst Count
  • GKOS 13
  • BOOT 12
  • Target Price
  • GKOS $122.08
  • BOOT $201.73
  • AVG Volume (30 Days)
  • GKOS 1.6M
  • BOOT 633.2K
  • Earning Date
  • GKOS 10-29-2025
  • BOOT 10-29-2025
  • Dividend Yield
  • GKOS N/A
  • BOOT N/A
  • EPS Growth
  • GKOS N/A
  • BOOT 36.30
  • EPS
  • GKOS N/A
  • BOOT 6.78
  • Revenue
  • GKOS $469,820,000.00
  • BOOT $2,071,382,000.00
  • Revenue This Year
  • GKOS $30.89
  • BOOT $18.78
  • Revenue Next Year
  • GKOS $24.36
  • BOOT $13.13
  • P/E Ratio
  • GKOS N/A
  • BOOT $27.62
  • Revenue Growth
  • GKOS 30.38
  • BOOT 17.82
  • 52 Week Low
  • GKOS $73.16
  • BOOT $86.17
  • 52 Week High
  • GKOS $163.71
  • BOOT $205.31
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 60.41
  • BOOT 48.62
  • Support Level
  • GKOS $80.91
  • BOOT $181.36
  • Resistance Level
  • GKOS $102.80
  • BOOT $191.02
  • Average True Range (ATR)
  • GKOS 4.63
  • BOOT 8.50
  • MACD
  • GKOS 1.07
  • BOOT -1.38
  • Stochastic Oscillator
  • GKOS 56.85
  • BOOT 11.90

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About BOOT Boot Barn Holdings Inc.

Boot Barn Holdings Inc operates specialty retail stores. The company sells western and work-related footwear, apparel, and accessories in the United States. It is a single operating segment, which includes net sales generated from its retail stores and e-commerce websites.

Share on Social Networks: